Brief: Phaxiam Therapeutics SA Says Net Loss For H1 2023 Was EUR 12.2 Mln, Compared With A Net Loss Of EUR 1 Mln For Same Period Of 2022

Phaxiam Therapeutics SA

21/09/2023 21:09

Sept 21 (Reuters) - Phaxiam Therapeutics SA  PHXM.PA :
    * NET LOSS FOR FIRST HALF OF 2023 WAS EUR 12.2 MILLION,
COMPARED
WITH A NET LOSS OF EUR 1 MILLION FOR SAME PERIOD OF 2022
    * CO BELIEVES THAT ITS CURRENT CASH POSITION CAN FUND ITS
CURRENT
PROGRAMS AND PLANNED OPERATING EXPENSES INTO Q2 OF 2024

Source text for Eikon:  ID:nGNE4qtKHc 
Further company coverage:  PHXM.PA 

 ((Reuters.Briefs@thomsonreuters.com;))